Barclays Capital Reaffirms Overweight Rating on MasTec (MTZ)

By admin | 7 years ago

MasTec (NYSE: MTZ)‘s stock had its “overweight” rating restated by equities researchers at Barclays Capital (NYSE: BCS) in a report issued on Monday.

Shares of MasTec traded down 0.97% during mid-day trading on Monday, hitting $17.31. MasTec has a 52 week low of $13.79 and a 52 week high of $23.00. The company has a market cap of $1.395 billion and a P/E ratio of 15.32.

MasTec last announced its earnings results on Thursday, May 3rd. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.01. The company’s revenue for the quarter was up 25.9% on a year-over-year basis. On average, analysts predict that MasTec will post $0.49 earnings per share next quarter.

Separately, analysts at Maxim Group upgraded shares of MasTec from a “hold” rating to a “buy” rating in a research note to investors on Friday, March 2nd. They now have a $25.00 price target on the stock.

Mastec, Inc. is a specialty contractor operating throughout the United States and across a range of industries.

About the author